Post by Alfonso Tedeschi Ph.D

Cell&Gene Therapy expert | iPSCs | Strategic Alliances | Committed to Patient Access to Essential Therapies | Regenerative Medicine

š–šž š­š«š®š¬š­ ššš§š¢š¦ššš„ š¦šØššžš„š¬ š›šžšœššš®š¬šž š­š”šžš² šœššš©š­š®š«šž šœšØš¦š©š„šžš±š¢š­š². š–šž šš¢š¬š­š«š®š¬š­š¬ šØš®š­šœšØš¦šžš¬ š°š”šžš§ š­š”šžš² ššØš§'š­ š­š«ššš§š¬š„ššš­šž š­šØ š”š®š¦ššš§š¬. At what point do we stop defending the system and start questioning it? Are we measuring complexity or predicting humans? This is my take on this tension after reading the recent JAMA viewpoint on unnecessary animal testing. #NAMs #organonchip #animalmodels #animaltesting #fda #ipsc #clinicaltrial #clinicaltranslation #OrganModels #EthicsInResearch #HumanRelevantResearch #InnovationInMedicine #EarlyDrugDiscovery #DrugDevelopment #Biotechnology #innovation

Post content